Apollo Endosurgery (APEN) has a profit margin of -51.84%, below the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2022
Trailing 12 months ending Dec 2022
The latest profit margin for APEN is -51.84% as of December 2022. That compares with -39.18% in the prior-year period — down 32.3% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Apollo Endosurgery's historical trend and sector peers before judging valuation or financial health.
Over the past year, APEN's profit margin moved from -39.18% to -51.84% — a 32.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Apollo Endosurgery's valuation or profitability profile.
Against Healthcare companies, APEN currently prints -51.84% for profit margin, while the sector average sits near 15.29%. That is roughly 439.0% below the sector mean. Large gaps often invite a closer look at Apollo Endosurgery's growth, margins, and balance sheet.
Profit Margin shows how effectively Apollo Endosurgery converts resources into returns. At -51.84%, APEN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -39.18% in the prior-year period — down 32.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting APEN's profit margin (-51.84%), review year-over-year change from -39.18%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.